Log in or Sign up for Free to view tailored content for your specialty!
Allergy/Asthma News
Particulate matter, ozone, allergens ‘worsening with climate change’
BOSTON — Amidst climate change, it is important that pulmonologists/critical care experts consider the impact worsening particulate matter, ozone and allergens have on their patients, according to a presentation at the CHEST Annual Meeting.
Cendakimab sustains ‘promising results’ for safety, efficacy in EoE at 48 weeks
PHILADELPHIA — A once-weekly 360 mg dose of cendakimab sustained improvements in symptoms and endoscopic/histologic features of eosinophilic esophagitis at 48 weeks, according to data presented at the ACG Annual Scientific Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Awareness of oral immunotherapy for food allergy varies by race, ethnicity
Caregivers of children with food allergy among minoritized racial and ethnic groups were less familiar with oral immunotherapy than caregivers of non-Hispanic white children with food allergy, according to a recent study.
Q&A: Epinephrine auto-injectors may not be adequate in preventing fatal anaphylaxis
Epinephrine autoinjectors may be associated with short-lived peak plasma levels, unpredictable cardiovascular responses as well as varying epinephrine absorption, according to a review published in Clinical and Experimental Allergy.
BLOG: Compliance issues when leasing your real estate to referral sources
The relationship between health care providers and referral sources can present complex legal challenges.
Only 46% of pediatric asthma caregivers agree that biologics are safe
BOSTON — Among caregivers of children with asthma, 54% did not “strongly agree” or “agree” that biologics are safe, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Vtama cream effective long-term for atopic dermatitis in adult, pediatric patients
Dermavant Sciences presented full results from its long-term extension trial of Vtama cream 1% for the treatment of atopic dermatitis at the Fall Clinical Dermatology Conference, the company announced in a press release.
Adbry shows long-term efficacy in atopic dermatitis
LEO Pharma presented full results from its long-term trial of Adbry for atopic dermatitis at the Fall Clinical Dermatology Conference, according to a company press release.
Chronic spontaneous urticaria symptoms improve with dupilumab through 24 weeks
BOSTON — Patients with chronic spontaneous urticaria experienced significant improvements through 24 weeks with dupilumab, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Poor allergic rhinitis control may worsen mental health symptoms
BOSTON — Poor allergic rhinitis control was associated with an increase of depressive and anxiety symptoms, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
-
Headline News
WikiGuidelines group publishes first new UTI guidance in 14 years
November 11, 20243 min read -
Headline News
Q&A: Industrial fires present unique respiratory health risks
November 11, 20244 min read -
Headline News
Physicians encouraged to conduct oral food challenges for infants, toddlers
November 12, 20247 min read
-
Headline News
WikiGuidelines group publishes first new UTI guidance in 14 years
November 11, 20243 min read -
Headline News
Q&A: Industrial fires present unique respiratory health risks
November 11, 20244 min read -
Headline News
Physicians encouraged to conduct oral food challenges for infants, toddlers
November 12, 20247 min read